Jinjiang Pang
Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Cell Cycle Proteins | 5 | 2008 | 71 |
Why?
|
Oligopeptides | 4 | 2003 | 56 |
Why?
|
Muscle, Smooth | 3 | 2001 | 69 |
Why?
|
GTPase-Activating Proteins | 2 | 2008 | 13 |
Why?
|
Drugs, Chinese Herbal | 2 | 2001 | 5 |
Why?
|
Phosphoproteins | 2 | 2008 | 86 |
Why?
|
Cholecalciferol | 1 | 2009 | 16 |
Why?
|
Muscle Contraction | 2 | 2001 | 77 |
Why?
|
Myocytes, Cardiac | 4 | 2003 | 40 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2008 | 59 |
Why?
|
Dietary Fats | 1 | 2009 | 33 |
Why?
|
Atherosclerosis | 1 | 2009 | 29 |
Why?
|
Angiotensin II | 2 | 2003 | 31 |
Why?
|
Phospholipase C gamma | 4 | 2008 | 17 |
Why?
|
Pulmonary Veins | 1 | 2009 | 22 |
Why?
|
Pulmonary Artery | 1 | 2009 | 58 |
Why?
|
Neovascularization, Physiologic | 1 | 2009 | 68 |
Why?
|
Histone Deacetylases | 1 | 2008 | 30 |
Why?
|
Pulmonary Alveoli | 1 | 2009 | 80 |
Why?
|
Growth Substances | 1 | 2003 | 51 |
Why?
|
Rats | 11 | 2001 | 530 |
Why?
|
Cells, Cultured | 9 | 2003 | 447 |
Why?
|
Apoptosis | 3 | 2003 | 265 |
Why?
|
Curcuma | 1 | 2001 | 1 |
Why?
|
Plants, Medicinal | 1 | 2001 | 15 |
Why?
|
Terminalia | 1 | 2001 | 2 |
Why?
|
Signal Transduction | 5 | 2003 | 313 |
Why?
|
Bronchodilator Agents | 1 | 2001 | 18 |
Why?
|
Estradiol | 1 | 2002 | 78 |
Why?
|
Uterus | 1 | 2001 | 49 |
Why?
|
Animals | 14 | 2001 | 1031 |
Why?
|
Rats, Sprague-Dawley | 5 | 2003 | 257 |
Why?
|
Animals, Newborn | 4 | 2003 | 175 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2008 | 94 |
Why?
|
Phosphorylation | 3 | 2008 | 224 |
Why?
|
Endothelial Cells | 2 | 2008 | 80 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2008 | 37 |
Why?
|
Acetylcholine | 2 | 2001 | 49 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2008 | 36 |
Why?
|
Trachea | 2 | 2001 | 50 |
Why?
|
Transfection | 3 | 2008 | 237 |
Why?
|
Ghrelin | 1 | 2009 | 2 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2003 | 431 |
Why?
|
Rabbits | 2 | 2001 | 252 |
Why?
|
Random Allocation | 1 | 2009 | 160 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2009 | 31 |
Why?
|
Pulmonary Circulation | 1 | 2009 | 42 |
Why?
|
Cell Surface Extensions | 1 | 2008 | 7 |
Why?
|
Lipoproteins | 1 | 2009 | 52 |
Why?
|
Aorta | 1 | 2009 | 69 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2010 | 35 |
Why?
|
Vesicular Transport Proteins | 1 | 2008 | 12 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2008 | 17 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 54 |
Why?
|
bcl-2-Associated X Protein | 2 | 2003 | 40 |
Why?
|
Epidermal Growth Factor | 1 | 2008 | 51 |
Why?
|
Receptor, Epidermal Growth Factor | 1 | 2008 | 54 |
Why?
|
Caspase 3 | 2 | 2003 | 56 |
Why?
|
Nitric Oxide | 1 | 2009 | 85 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2008 | 40 |
Why?
|
Oncogene Proteins | 1 | 2008 | 26 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2008 | 64 |
Why?
|
Cell Line | 2 | 2008 | 375 |
Why?
|
N-Methylaspartate | 1 | 2006 | 18 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2006 | 27 |
Why?
|
Survival Rate | 1 | 2009 | 250 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2003 | 71 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2008 | 77 |
Why?
|
Heart Ventricles | 1 | 2007 | 86 |
Why?
|
Cell Division | 1 | 2009 | 273 |
Why?
|
Cell Movement | 1 | 2008 | 163 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 38 |
Why?
|
Collagen | 1 | 2007 | 118 |
Why?
|
Glucose | 1 | 2008 | 120 |
Why?
|
Cachexia | 1 | 2005 | 10 |
Why?
|
Mitochondria, Heart | 1 | 2006 | 20 |
Why?
|
Rats, Wistar | 2 | 2001 | 75 |
Why?
|
Mice, Knockout | 1 | 2009 | 265 |
Why?
|
Proto-Oncogene Proteins | 2 | 2003 | 113 |
Why?
|
Tetrazolium Salts | 1 | 2003 | 18 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2003 | 27 |
Why?
|
Growth Hormone-Releasing Hormone | 1 | 2003 | 5 |
Why?
|
Vasoconstrictor Agents | 1 | 2003 | 26 |
Why?
|
Fibroblasts | 1 | 2007 | 179 |
Why?
|
In Situ Nick-End Labeling | 1 | 2003 | 65 |
Why?
|
DNA | 1 | 2009 | 262 |
Why?
|
Coloring Agents | 1 | 2003 | 42 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 318 |
Why?
|
Myocardial Contraction | 1 | 2003 | 52 |
Why?
|
Male | 4 | 2001 | 1553 |
Why?
|
Thiazoles | 1 | 2003 | 50 |
Why?
|
Caspases | 1 | 2003 | 58 |
Why?
|
Oxidative Stress | 1 | 2006 | 119 |
Why?
|
Muscle Relaxation | 1 | 2002 | 18 |
Why?
|
Histamine | 1 | 2002 | 17 |
Why?
|
Guinea Pigs | 1 | 2002 | 76 |
Why?
|
Female | 3 | 2001 | 1643 |
Why?
|
Heart Failure | 1 | 2005 | 106 |
Why?
|
Flow Cytometry | 1 | 2003 | 216 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 243 |
Why?
|
Calcium | 2 | 2003 | 208 |
Why?
|
Mice | 2 | 2008 | 623 |
Why?
|
Action Potentials | 1 | 2001 | 77 |
Why?
|
Humans | 4 | 2008 | 1856 |
Why?
|
RNA, Small Interfering | 2 | 2008 | 116 |
Why?
|
Asthma | 1 | 2002 | 97 |
Why?
|
Enzyme Activation | 2 | 2006 | 177 |
Why?
|
Cell Membrane Structures | 1 | 2010 | 6 |
Why?
|
Phorbol 12,13-Dibutyrate | 1 | 2010 | 11 |
Why?
|
Mutant Proteins | 1 | 2010 | 20 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 32 |
Why?
|
src-Family Kinases | 1 | 2010 | 30 |
Why?
|
Tyrosine | 1 | 2010 | 71 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2008 | 4 |
Why?
|
Matrix Metalloproteinase 14 | 1 | 2008 | 12 |
Why?
|
Actins | 1 | 2010 | 112 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2008 | 28 |
Why?
|
Sorting Nexins | 1 | 2008 | 2 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2008 | 7 |
Why?
|
Endosomes | 1 | 2008 | 16 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2008 | 10 |
Why?
|
Two-Hybrid System Techniques | 1 | 2008 | 42 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2008 | 21 |
Why?
|
RNA Interference | 1 | 2008 | 75 |
Why?
|
RNA, Messenger | 2 | 2005 | 394 |
Why?
|
Recombinant Proteins | 1 | 2010 | 290 |
Why?
|
Protein Kinases | 1 | 2008 | 64 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 137 |
Why?
|
Extracellular Matrix | 1 | 2008 | 79 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 58 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2008 | 67 |
Why?
|
Dizocilpine Maleate | 1 | 2006 | 10 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2006 | 18 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2006 | 21 |
Why?
|
Acetylcysteine | 1 | 2006 | 42 |
Why?
|
Protein Structure, Tertiary | 1 | 2008 | 163 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 216 |
Why?
|
Cytochromes c | 1 | 2006 | 29 |
Why?
|
Receptors, Ghrelin | 1 | 2005 | 2 |
Why?
|
Hypophysectomy | 1 | 2005 | 11 |
Why?
|
Creatine Kinase | 1 | 2005 | 37 |
Why?
|
Catecholamines | 1 | 2005 | 40 |
Why?
|
Ventricular Remodeling | 1 | 2005 | 21 |
Why?
|
Antioxidants | 1 | 2006 | 84 |
Why?
|
Glutathione | 1 | 2006 | 65 |
Why?
|
Cell Survival | 1 | 2006 | 229 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 62 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2005 | 41 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 112 |
Why?
|
Pyruvic Acid | 1 | 2003 | 12 |
Why?
|
Cell Proliferation | 1 | 2007 | 227 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2005 | 35 |
Why?
|
Lactic Acid | 1 | 2003 | 44 |
Why?
|
Coronary Circulation | 1 | 2003 | 41 |
Why?
|
Blood Pressure | 1 | 2005 | 205 |
Why?
|
Biological Transport | 1 | 2003 | 129 |
Why?
|
Heart | 1 | 2003 | 88 |
Why?
|
Peptide Fragments | 1 | 2003 | 144 |
Why?
|
Myocardium | 1 | 2003 | 119 |
Why?
|
Heart Rate | 1 | 2003 | 138 |
Why?
|
Time Factors | 1 | 2006 | 896 |
Why?
|
